|
KMID : 0624620210540010059
|
|
BMB Reports
2021 Volume.54 No. 1 p.59 ~ p.69
|
|
|
Genome editing of immune cells using CRISPR/Cas9
|
|
Kim Se-Gi
Hupperetz Cedric
Lim Seong-Joon
Kim Chan-Hyuk
|
|
|
Abstract
|
|
|
|
The ability to read, write, and edit genomic information in living organisms can have a profound impact on research, health, economic, and environmental issues. The CRISPR/Cas system, recently discovered as an adaptive immune system in prokaryotes, has revolutionized the ease and throughput of genome editing in mammalian cells and has proved itself indispensable to the engineering of immune cells and identification of novel immune mechanisms. In this review, we summarize the CRISPR/ Cas9 system and the history of its discovery and optimization. We then focus on engineering T cells and other types of immune cells, with emphasis on therapeutic applications. Last, we describe the different modifications of Cas9 and their recent applications in the genome-wide screening of immune cells.
|
|
|
KEYWORD
|
|
|
CRISPR/Cas9, Engineered T cells, Genome editing, Genome-wide screening, HSPC engineering
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|